FBIO: Fortress Biotech Inc Price Target Chart

Corporate company logo of Fortress Biotech Inc (FBIO)

Fortress Biotech, Inc. (FBIO) operates as an investment hub that acquires and scales promising biomed projects for the global pharmaceutical market, which is confirmed by the market dynamics reflected in the quotes at the level of 4.98. The efficiency of bringing products to medical application is ensured through the digital optimization of transport flows. Meanwhile, the company's environmental focus is centered on transitioning to paperless documentation in patent trading.

Fortress (FBIO): Price Target Chart from 07/04/2022 to 11/11/2026

Analytical breakdowns for Fortress (FBIO)

- share price and expert price forecast:
Quote Chart fortressbiotech.com|FBIO - Analyst Consensus Forecast
- market capitalization information:
Market Value Fortress|FBIO - Enterprise Value
- issuer book value statistics:
Net Assets per Share Fortress Biotech|FBIO - Company Book Value|Market-to-Book Ratio fortressbiotech.com|FBIO - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Fortress Biotech, Inc.|FBIO - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Fortress Biotech Corp|FBIO - Company Debts|Debts to Net Assets Fortress|FBIO - Company Long-Term Debts|Company Current Liabilities Fortress Biotech|Immediate Liquidity fortressbiotech.com
- net income and valuation ratios data:
FBIO - Company Net Income|Expected Profit Fortress Biotech, Inc.|FBIO - Price to Earnings Ratio|Future Price to Earnings Fortress Biotech Inc|FBIO - PEG Multiple|EV/EBITDA Multiple Fortress|FBIO - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Fortress Biotech|FBIO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months fortressbiotech.com|FBIO - Earnings per share growth in current year|Expected net earnings per share growth next year Fortress Biotech, Inc.
Fundamental company analysis:FBIO, fortressbiotech.com
Original product of Fortress Biotech, Inc.

The consensus forecast represents a weighted average of independent fair value estimates, reflecting the professional community's aggregate expectations regarding the company's fundamental potential. By analyzing changes in the consensus valuation of Fortress Biotech, Inc. (FBIO), an investor can capture the market's reaction to geopolitical barriers in the supply of components for oncology drugs, which directly impact the revision of target prices.

Competing companies

NVCR: Forecast Levels Chart|Analyst Consensus Forecast DRTS (Alpha Tau Medical)|Acrivon Therapeutics Inc - Price Target Chart|Allarity - Analyst Consensus Forecast